FMC acted as Canadian investor counsel in the $41.4M financing of Variation Biotechnologies Inc., which was the largest reported venture capital financing in Canada in 2006.
FMC also acted as Company counsel or investor counsel on seven of the largest 25 reported venture capital financing transactions in 2006.
FMC is a founding partner of the Canada-California Strategic Innovation Partnership (C2SIP).  C2SIP advocates changes to Canadian tax law that remove impediments to investments in Canadian tech companies by U.S. and other non-Canadian investors.


Receive our latest technology updates
Signup Now
Technology
Fraser Milner Casgrain LLP serves the full spectrum of technology clients, including technology creators, users and investors.  Consisting of our Technology Transactions and Tech Companies | Venture Capital sub-groups, the Technology Law Practice Group has advised hundreds of technology-related businesses: from startups to large multinational companies; from seed and venture capital funds to financial institutions. 

Our Technology Transactions Group advises clients on all aspects relating to the use and commercial exploitation of technology, including the licensing, distribution and creation of technology and intellectual property rights.  Our Technology Companies/Venture Capital Group advises technology businesses regarding their formation and financing, including facilitating introductions to potential investors through our extensive contacts in Canada and the United States. FMC also regularly advises on "exit" transactions including M&A and IPO's.

FMC is committed to building expertise in emerging legal fields. Our in-depth experience and contacts in the technology and financing sectors allows us to view these sectors from the "inside-out" and to add value not only in advising on legal issues, but also in providing strategic insight.  This insight, together with our emphasis on providing service of the highest quality, has allowed us to earn the respect of, and build strong and enduring relationships with, our clients.


REPRESENTATIVE WORK
Acted as Canadian counsel to Irdeto Holdings on its $72.5M acquisition of Cloakware Inc., a Virginia-based software company
Counsel to Dundee Securities Corporation in $22 million bought deal financing of ConjuChem Biotechnologies Inc.
Represented BTI Photonic Systems Inc. in its US$12M Series D financing (September 2007)
Acted as Canadian counsel for Delphi Ventures and OrbiMed Advisors in US$32M Series B Financing of Neuraxon Inc. (August 2007)
Represented Celtic House Venture Partners Fund III LP and GrowthWorks Canada Ltd. in the US$10M Series A financing of Morega Systems Inc. (July 2007)
Represented a developer of optical networking equipment in the negotiation of a multi-faceted development and supply agreement with a leading international supplier of IT and network solutions (July 2007)

PUBLICATIONS



Key Contacts






MontréalOttawaTorontoEdmontonCalgaryVancouverNew York
Contact Us | Media Room | Site Map | Legal & Privacy
© 2007 Fraser Milner Casgrain LLP